HealthPeople + Talent 18 Mar 2021 Our investment in Wefarm We always want to back the boldest, most mission-driven companies, and they don’t come more pioneering than Wefarm. Since its founding in 2015,... Written by alice Read more
Health 16 Mar 2021 Ibex Medical Analytics: clinical-grade AI solution for cancer diagnostics and analysis Why we invested in Ibex Medical Analytics, a startup solving the cancer diagnosis problem with clinical-grade AI Written by Tosin Agbabiaka Read more
Health 25 Feb 2021 8 emerging trends on the health tech horizon Even before Covid, health technology was one of the fastest growing investment sectors in the world. This pace has now more than doubled as a... Written by Neel Bhula Read more
Health 25 Jan 2021 Announcing a major health boost for Octopus Ventures Octopus Ventures boosts its health tech investment capabilities Written by Alliott Cole Read more
Health 7 Jan 2021 Our investment in Inflow Read about Octopus Ventures investment in Inflow, a dedicated service, specifically addressing the needs of people with ADHD. Written by Will Gibbs Read more
Health 22 Jul 2020 Why Fertility is in our future Kamran Adle explains why Octopus Venture’s Future of Health pod is diving deep into Fertility Written by alice Read more
Health 29 Jun 2020 Digital Therapeutics: the trend within Digital Health that cannot be ignored With two portfolio companies leading the way in this field, Will Gibbs explains why he believes this sector is central to the future of Digital Health. Written by Will Gibbs Read more
HealthPeople + Talent 30 Mar 2020 Our investment in Pelago (formerly Quit Genius) The Pelago team have built a product that has demonstrated a 53% quit rate, just one reason why Octopus Ventures invested Written by Fred Ellis Read more
Health 25 Feb 2020 The Antibiotic crisis: why the resistance from investors? It wasn’t so long ago that cutting your finger could be a life-threatening event. Then the discovery of antibiotics made the world a much,... Written by The Bio Tech team Read more
Health 30 Oct 2019 Serious business: the opportunities in men’s health taboos. A men’s health startup issued a member-get-member referral promotion recently. Despite the serious addressing of issues like erectile dysfunction... Written by Octopus Ventures Read more
Health 25 Oct 2019 Nemesis Bio: using CRISPR-Cas9 to tackle antibiotic resistance Frank Massam, PhD and Professor Conrad Lichtenstein, PhD are co-founders of Nemesis Bioscience. This biopharmaceutical company is developing... Written by Octopus Ventures Read more
Health 4 Oct 2019 Chances of survival: Healthtech and the rigours of regulation FDA approval’s vital for healthtech startups. How do you get it? Written by Octopus Ventures Read more